Suppr超能文献

一氧化氮合酶抑制和内皮素-1受体阻断对扩张型心肌病和缺血性心肌病体外乙酰胆碱诱导的冠状动脉收缩的影响。

Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies.

作者信息

Thorin E

机构信息

Department of Surgery, University of Montreal, and the Montreal Heart Institute, Quebec, Canada.

出版信息

J Cardiovasc Pharmacol. 2001 Jul;38(1):90-8. doi: 10.1097/00005344-200107000-00010.

Abstract

The normal dilatory response to acetylcholine (ACH) is reduced in coronary vessels from patients with dilated cardiomyopathy (DCM) and reversed to a contraction in patients with coronary artery disease (CAD) and ischemic cardiomyopathy (ICM). This study investigated the influence of nitric oxide synthase inhibition and endothelin (ET)-1 receptor blockade on the reactivity to ACH of coronary arteries isolated from patients with end-stage congestive heart failure (CHF) associated or not with CAD. Small (approximately 400 microm) epicardial right coronary arteries were isolated from explanted hearts of patients undergoing transplantation for DCM or ICM. Segments were mounted on a wire myograph to record changes in isometric tension. ACH (1 microM) dilated pre-contracted vessels from DCM hearts but contracted pre-contracted vessels from ICM hearts. In the absence of pre-contraction, ACH (10(-9)-3 x 10(-5) M) induced a small contraction of rings from DCM hearts and a larger contraction (p < 0.05) of rings from ICM hearts. N(omega)-nitro-L-arginine (L-NNA, 100 microM), a NO synthase inhibitor, increased (p < 0.05) sensitivity and maximal response to ACH of vessels from DCM hearts only. In the presence of L-NNA, blockade of ET(A) with BQ123 (1 microM) prevented the effects of L-NNA in DCM, whereas blockade of ET(A/B) receptors with bosentan (10 microM) only reduced vascular sensitivity to ACH without significantly reducing the maximal contraction to ACH in DCM. The antagonists had no effects in vessels from ICM hearts. ACH, however, induced similar contractions of vessels without endothelium in DCM and ICM. These results suggest that ACH induces a contraction by stimulating smooth muscle muscarinic receptors. In coronary arteries isolated from DCM hearts, the contraction is regulated by NO and ET-1, whereas these factors seem to have little influence in ICM. This suggests that endothelial muscarinic receptors are either not expressed or uncoupled in ICM hearts.

摘要

扩张型心肌病(DCM)患者冠状动脉对乙酰胆碱(ACH)的正常舒张反应减弱,而冠状动脉疾病(CAD)和缺血性心肌病(ICM)患者的该反应则逆转至收缩。本研究调查了一氧化氮合酶抑制和内皮素(ET)-1受体阻断对从伴有或不伴有CAD的终末期充血性心力衰竭(CHF)患者分离出的冠状动脉对ACH反应性的影响。从因DCM或ICM接受移植的患者的离体心脏中分离出小的(约400微米)心外膜右冠状动脉。将血管段安装在钢丝肌动描记器上以记录等长张力的变化。ACH(1微摩尔)使DCM心脏的预收缩血管舒张,但使ICM心脏的预收缩血管收缩。在没有预收缩的情况下,ACH(10^-9 - 3×10^-5摩尔)诱导DCM心脏的血管环出现小的收缩,而ICM心脏的血管环出现更大的收缩(p < 0.05)。一氧化氮合酶抑制剂N(ω)-硝基-L-精氨酸(L-NNA,100微摩尔)仅增加(p < 0.05)DCM心脏血管对ACH的敏感性和最大反应。在存在L-NNA的情况下,用BQ123(1微摩尔)阻断ET(A)可防止L-NNA对DCM的作用,而用波生坦(10微摩尔)阻断ET(A/B)受体仅降低血管对ACH的敏感性,而不会显著降低DCM中对ACH的最大收缩。拮抗剂对ICM心脏的血管没有作用。然而,ACH在DCM和ICM中诱导无内皮血管出现类似的收缩。这些结果表明,ACH通过刺激平滑肌毒蕈碱受体诱导收缩。在从DCM心脏分离出的冠状动脉中,收缩受一氧化氮和ET-1调节,而这些因素在ICM中似乎影响很小。这表明内皮毒蕈碱受体在ICM心脏中要么不表达,要么解偶联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验